Correction to "Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)" [The Lancet Regional Health - Europe 41 (2024) 100915]

Lancet Reg Health Eur. 2024 Oct 22:46:101120. doi: 10.1016/j.lanepe.2024.101120. eCollection 2024 Nov.

¹ University Hospital of Montpellier and IDESP, University of Montpellier - INSERM - INRIA PreMediCal, Montpellier, France.
² Department of Medical Pharmacology, Bordeaux University, Bordeaux, France.
³ Department of Internal Medicine, Lariboisière Hospital, AP-HP, Université Paris-Cité, Paris, France.
⁴ Institut de l'Enfant, Clinique Marcel Sembat, Boulogne Billancourt, France.
⁵ IQVIA, RWS, France.
⁶ Stallergenes Greer, France.
⁷ VIM Suresnes - UMR_0892 & Clinical Research Unit, Airway Diseases Department, Foch Hospital, University Versailles Saint-Quentin, Suresnes, France.

Abstract

[This corrects the article DOI: 10.1016/j.lanepe.2024.100915.].